Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 214-233
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.214
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.214
Ref. | Case | TNM |
Anderegg et al[11], 2017 | 313 | Stage I-III |
Esophageal Cancer Study Group Participating Centers[12], 2019 | 268 | Stage I-III |
Gawad et al[13], 2015 | 370 | Stage II-IV |
Markar et al[14], 2017 | 608 | Stage II-III |
Tian et al[15], 2020 | 827 | Stage I-IV |
Nakashima[16], 2018 | 120 | Stage II-IV |
Park et al[17], 2020 | 38 | Stage II-III |
Pucher et al[18], 2020 | 284 | Stage I-III |
Samson et al[19], 2016 | 7388 | Stage I-III |
Spicer et al[20], 2016 | 214 | Stage IIIA |
Stiles et al[21], 2019 | 338 | Stage I-IV |
Swisher et al[22], 2010 | 157 | Stage I-III |
Tang et al[23], 2023 | 264 | Stage II-IV |
Tercioti et al[24], 2011 | 97 | Stage I-III |
Tiesi et al[25], 2017 | 297 | Stage II-IV |
Jiang et al[26], 2022 | 299 | Stage II-III |
Zhou et al[27], 2020 | 423 | NA |
- Citation: Yuan MX, Cai QG, Zhang ZY, Zhou JZ, Lan CY, Lin JB. Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis. World J Gastrointest Oncol 2024; 16(1): 214-233
- URL: https://www.wjgnet.com/1948-5204/full/v16/i1/214.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.214